Weighted Average Number of Shares Outstanding, Diluted of Surface Oncology, Inc. from 31 Mar 2017 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Surface Oncology, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2017 to 30 Jun 2023.
  • Surface Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2023 was 60,717,899, a 11% increase year-over-year.
  • Surface Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 55,761,386, a 26% increase from 2021.
  • Surface Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 44,243,317, a 16% increase from 2020.
  • Surface Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 38,141,793, a 37% increase from 2019.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Surface Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 60,717,899 +6,063,077 +11% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 60,627,993 +10,811,209 +22% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 55,761,386 +11,518,069 +26% 01 Oct 2022 31 Dec 2022 8-K 03 Jul 2023 Q4
Q3 2022 59,054,486 +13,817,711 +31% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 54,654,822 +11,020,476 +25% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 49,816,784 +8,197,422 +20% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 44,243,317 +6,101,524 +16% 01 Oct 2021 31 Dec 2021 8-K 03 Jul 2023 Q4
Q3 2021 45,236,775 +5,232,220 +13% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 43,634,346 +10,215,934 +31% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 41,619,362 +10,701,910 +35% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 38,141,793 01 Oct 2020 31 Dec 2020 8-K 03 Jul 2023 Q4
Q3 2020 40,004,555 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 33,418,412 +5,573,276 +20% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 30,917,452 +3,091,754 +11% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q2 2019 27,845,136 +6,249,550 +29% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2
Q1 2019 27,825,698 +23,691,054 +573% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q2 2018 21,595,586 +19,181,707 +795% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 4,134,644 +1,735,379 +72% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q2 2017 2,413,879 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 2,399,265 01 Jan 2017 31 Mar 2017 10-Q 29 May 2018 2018 Q1

Surface Oncology, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 55,761,386 +11,518,069 +26% 01 Jan 2022 31 Dec 2022 8-K 03 Jul 2023
2021 44,243,317 +6,101,524 +16% 01 Jan 2021 31 Dec 2021 8-K 03 Jul 2023
2020 38,141,793 +10,286,881 +37% 01 Jan 2020 31 Dec 2020 8-K 03 Jul 2023
2019 27,854,912 +7,864,139 +39% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022 2021 FY
2018 19,990,773 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.